COVID-19’s effects on the supplement supply chain – podcast

Concern is high, and answers are few as the dietary supplement industry faces the pandemic COVID-19, the respiratory diseases caused by a novel coronavirus that originated in Wuhan, China. By press time, COVID-19 has reached 108 countries, infected nearly 125,000 people, and more than 4,500 people have died. Industries across the world are considering how this virus will play out, and how it will affect their people and products. For supplement brands, special considerations focus on supply chain concerns, FDA enforcement and illegal marketing claims. In this podcast, Jim C. Griffiths, senior vice president of international and scientific affairs, Council for Responsible Nutrition (CRN), discusses the issues facing supplement brands with Sandy Almendarez, content director, Informa Markets.